SCHEMBL14907940

SCHEMBL14907940

Cc1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 8/20 0.65
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 3/20 0.43
MAPK1 P28482 2/20 0.43
RECQL P46063 1/20 0.43
TSHR P16473 1/20 0.42
HK1 P19367 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
TYMP P19971 1/20 0.41
APEX1 P27695 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTT P42858 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18540012 0.89 GRK6 (0.55) GRK6MEN1KMT2AMAPTMAPK1
SCHEMBL14907758 0.87 GRK6 (0.64) GRK6MAPTMAPK1TSHRTYMP
SCHEMBL14907891 0.86 GRK6 (0.67) GRK6MEN1KMT2AALDH1A1LMNA
SCHEMBL17213026 0.84 GRK6 (0.46) GRK6KMT2AMAPTTSHRTYMP
SCHEMBL17212977 0.83 GRK6 (0.56) GRK6TYMP
SCHEMBL16171164 0.82 GRK6 (0.46) GRK6KMT2ATYMPALDH1A1TDP1
SCHEMBL16171060 0.81 GRK6 (0.47) GRK6MEN1KMT2AMAPTTYMP
SCHEMBL6405125 0.81 TYMP (0.60) GRK6MAPTTYMPALDH1A1HTT
SCHEMBL14907730 0.81 GRK6 (0.71) GRK6MEN1KMT2AMAPTALDH1A1
SCHEMBL18539895 0.80 MAPT (0.46) GRK6MEN1KMT2AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885MEN1 2721/4885KMT2A 3122/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885MEN1 2721/4885KMT2A 3122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.